{"schema_version":"secwatch.filing_event.v1","accession":"0000899923-23-000066","form_type":"8-K","ticker":"MYGN","cik":"0000899923","company_name":"MYRIAD GENETICS INC","filed_at":"2023-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.342128+00:00","generated_at":"2026-06-10T01:56:15.207858+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Myriad Genetics secures multi-year UnitedHealthcare contract renewal through 2027","bullets":["New agreement covers tests: MyRisk, MyChoice CDx, BRACAnalysis CDx, Foresight, Prequel, GeneSight, Prolaris.","Contract effective Jan 1, 2024 to Dec 31, 2027; specific pricing terms not disclosed.","Company reiterates long-term financial targets announced at Sep 19, 2023 investor day, consistent with this renewal."],"urls":{"canonical":"https://secwatch.observer/filing/0000899923-23-000066","json":"https://secwatch.observer/filing/0000899923-23-000066.json","markdown":"https://secwatch.observer/filing/0000899923-23-000066.md","text":"https://secwatch.observer/filing/0000899923-23-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000066/0000899923-23-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899923/000089992323000066/mygn-20231010.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T01:56:15.207858+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}